TuHURA Biosciences
HURA
20 hedge funds and large institutions have $972K invested in TuHURA Biosciences in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 8 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
9% less funds holding
Funds holding: 22 → 20 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
34% less capital invested
Capital invested by funds: $1.48M → $972K (-$507K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$166K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$51.4K |
| 3 |
Millennium Management
New York
|
+$10K |
| 4 |
LPL Financial
San Diego,
California
|
+$5.22K |
| 5 |
ACA
Affinity Capital Advisors
Berkeley,
California
|
+$4.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$136K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$52.3K |
| 3 |
BlackRock
New York
|
-$36K |
| 4 |
VF
Virtu Financial
New York
|
-$16K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$6.1K |
HURA Hedge Fund Activity: Q2 2022 in Review
20 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2022, worth a combined $972K — down 34% from $1.48M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of HURA and 6 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $166K. The largest seller was Nantahala Capital Management, cutting an estimated $136K.
- 20 institutional investors held TuHURA Biosciences (HURA) as of Q2 2022, down from 22 in Q1 2022.
- Funds reported $972K of TuHURA Biosciences stock for Q2 2022, down 34% quarter-over-quarter.
- 6 funds opened new TuHURA Biosciences positions in Q2 2022 and 8 closed out, a net change of -2 holders.
- The largest TuHURA Biosciences buyer in Q2 2022 was Renaissance Technologies, an estimated $166K added.
- The largest TuHURA Biosciences seller in Q2 2022 was Nantahala Capital Management, an estimated $136K sold.
Based on aggregated 13F filings for Q2 2022.